Kidney Cancer Research Bureau

Homepage: bucare.org

Alternate name: Bureau for Cancer Research

ROR: 00th63n98

OpenAlex ID: I4405267011

Challenges to effective cancer control in China, India, and Russia

2014 · Paul E Goss, Kathrin Strasser-Weippl, et al. · The Lancet Oncology · 505

Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma

2009 · Ilya V Tsimafeyeu, Lev V Demidov, et al. · Journal of Experimental & Clinical Cancer Research · 37

PDF

Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry

2017 · Ilya Tsimafeyeu, Tatiana Zolotareva, et al. · Clinical Genitourinary Cancer · 34

Phase II, Multicenter, Uncontrolled Trial of Single-agent Capecitabine in Patients With Non-clear Cell Metastatic Renal Cell Carcinoma

2011 · Ilya Tsimafeyeu, Lev Demidov, et al. · American Journal of Clinical Oncology · 24

OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model

2013 · Ilya Tsimafeyeu, Elina Zaveleva, et al. · Investigational New Drugs · 21

FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma

2016 · I. Tsimafeyeu, A. Khasanova, et al. · Clinical & Translational Oncology · 14

COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation

2020 · Ilya Tsimafeyeu, Galina Alekseeva, et al. · Clinical Genitourinary Cancer · 12

PDF

Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection

2020 · Ilya Tsimafeyeu, Rustem Gafanov, et al. · Cancer Immunology Immunotherapy · 12

Expression of Receptor Tyrosine Kinases on Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes in Patients with Renal Cell Carcinoma and Healthy Donors

2020 · Ilya Tsimafeyeu, Maria Volkova, et al. · Oncology · 11

Adjuvant therapy for renal cell carcinoma in 2023: hopes and disappointments

2023 · Ilya Tsimafeyeu, Michael F. Basin, et al. · World Journal of Urology · 10

Everolimus in patients with metastatic renal cell carcinoma previously treated with bevacizumab: a prospective multicenter study CRAD001LRU02T

2014 · Ilya Tsimafeyeu, Anton Snegovoy, et al. · Targeted Oncology · 10

Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies

2021 · Ilya Tsimafeyeu, Maria Volkova, et al. · Journal of Hematology & Oncology · 9

PDF

A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models

2024 · I. Tsimafeyeu, P. Makhov, et al. · Immuno-Oncology Technology · 7

PDF

Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma: A Phase 2 Randomized Study FARETES

2021 · Ilya Tsimafeyeu, Yulia Tishova, et al. · American Journal of Clinical Oncology · 7

Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study

2024 · Ilya Tsimafeyeu, Vyacheslav Chubenko, et al. · Current Oncology · 6

PDF

Survival of patients with metastatic bladder cancer in the Russian Federation: results of a multicenter registry study URRU

2021 · I. V. Tsimafeyeu, G. N. Alekseeva, et al. · Cancer Urology · 6

PDF

Life expectancy in patients with metastatic renal cell carcinoma in the Russian Federation: results of the RENSUR3 multicenter registry study

2019 · I. V. Tsimafeyeu, I. S. Varlamov, et al. · Malignant tumours · 6

PDF

Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx

2019 · Ilya Tsimafeyeu, Pavel Borisov, et al. · Targeted Oncology · 6

Treatment options for renal cell carcinoma in patients with von Hippel-Lindau disease

2010 · Ilya Tsimafeyeu, Lev Demidov · Journal of Cancer Research and Therapeutics · 6

Multicenter phase 2 study of intrapleural nivolumab in patients with metastatic non-small cell lung cancer and pleural effusion.

2023 · Ilya Tsimafeyeu, Vadim Goutnik, et al. · PubMed Central · 5

PDF

The Problem of Incentives and Output

1920 · Ordway Tead · The Annals of the American Academy of Political and Social Science · 5

Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy

2025 · Ilya Tsimafeyeu · Exploration of Targeted Anti-tumor Therapy · 4

PDF

Expression of the Vascular Endothelial Growth Factor and Its Receptors (vegfr-1 and Vegfr-2) in Primary Tumor Cells in Patients With Renal Cancer

2021 · D. A. Khochenkov, M. I. Volkova, et al. · Siberian Journal of Oncology · 4

PDF

Nivolumab: 5 Years Since FDA Approval of the First Checkpoint Inhibitor for Renal Cell Carcinoma

2021 · Ilya Tsimafeyeu · Kidney Cancer · 4

PDF

Nivolumab Combined with Chemotherapy in FGFR2 and PD-L1 Co-Expressing Metastatic Gastric Cancer: A Prospective Phase 2 NIVOFGFR2 Study

2025 · Ilya Tsimafeyeu, Gunel Musayeva, et al. · Journal of Gastrointestinal Cancer · 3

Works count: 82

Citation count: 822